Cite

HARVARD Citation

    Kosaka, A. et al. (2021). A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy. Cancer science. 112 (7), pp. 2705-2713. [Online]. 
  
Back to record